Clinical Trials Browser

Completed × Adenocarcinoma × Everolimus × Clear all

NCT02890069 2023-01-11

A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat

Phase 1 Completed

BreastGastrointestinalGenitourinaryThoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT00719264 2017-03-20

Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer

Phase 2 Completed

365 enrolled 14 charts

Margins of Excision, Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell

NCT00688753 2016-09-02

MACS0460

Phase 2 Completed

92 enrolled 12 charts

Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell

NCT00597506 2012-12-27

BEV/EV

Phase 2 Completed

50 enrolled 7 charts

Adenocarcinoma